Lifestyle Approach and Medical Therapy of Lower Extremity Peripheral Artery Disease
Lower extremity peripheral artery disease (PAD) is common among patients with several risk factors, such as elderly, smoking, hypertension, and diabetes mellitus. Notably, PAD is associated with a higher risk of cardiovascular complications. Non-invasive interventions are beneficial to improve morbi...
Gespeichert in:
Veröffentlicht in: | The American journal of medicine 2024-03, Vol.137 (3), p.202-209 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 209 |
---|---|
container_issue | 3 |
container_start_page | 202 |
container_title | The American journal of medicine |
container_volume | 137 |
creator | Krittanawong, Chayakrit Escobar, Johao Virk, Hafeez Ul Hassan Alam, Mahboob Virani, Salim Lavie, Carl J. Narayan, K M Venkat Sharma, Raman |
description | Lower extremity peripheral artery disease (PAD) is common among patients with several risk factors, such as elderly, smoking, hypertension, and diabetes mellitus. Notably, PAD is associated with a higher risk of cardiovascular complications. Non-invasive interventions are beneficial to improve morbidity and mortality among patients with PAD. Traditional risk factors like smoking, diabetes mellitus, hypertension, and dyslipidemia play a significant role in the development of PAD. Still, additional factors such as mental health, glycemic control, diet, exercise, obesity management, lipid-lowering therapy, and antiplatelet therapy have emerged as important considerations. Managing these factors can help improve outcomes and reduce complications in PAD patients. Antiplatelet therapy with aspirin or clopidogrel is recommended in PAD patients, with clopidogrel showing more significant benefits in symptomatic PAD individuals. Managing several risk factors is crucial for improving outcomes and reducing complications in patients with PAD. Further research is also needed to explore the potential benefits of novel therapies. Ultimately, a comprehensive approach to PAD management is essential for improving morbidity and mortality among patients with this condition. |
doi_str_mv | 10.1016/j.amjmed.2023.10.028 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2892012511</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S000293432300709X</els_id><sourcerecordid>2892012511</sourcerecordid><originalsourceid>FETCH-LOGICAL-c408t-d7df2535110afe0aaed53f35b311582de19d4f5eab7beab2f7991f9997e72dc3</originalsourceid><addsrcrecordid>eNp9kEtLAzEQx4Motla_gUiOXrbm0XQ3F6HU-oCKgr2HNJnQlN3ummzV_fZmab16mWFm_vP6IXRNyZgSOr3bjnW1rcCOGWE8pcaEFSdoSIUQWU6n7BQNCSEsk3zCB-gixm0KiRTTczTguSyIzMkQfSy9g9h2JeBZ04Ramw3WO4tfwXqjS7zaQNBNh2uHl_U3BLz4aQNUvu3wOwTf9OUSz0ILocMPPoKOcInOnC4jXB39CK0eF6v5c7Z8e3qZz5aZmZCizWxuHRNcUEq0A6I1WMEdF2tOqSiYBSrtxAnQ63ydDHO5lNRJKXPImTV8hG4PY9PZn_v0hKp8NFCWegf1PipWSEYoS_OTdHKQmlDHGMCpJvhKh05RonqaaqsONFVPs88mmqnt5rhhv-5rf01_-JLg_iCA9OaXh6Ci8bAzCV4A0ypb-_83_AK14ohb</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2892012511</pqid></control><display><type>article</type><title>Lifestyle Approach and Medical Therapy of Lower Extremity Peripheral Artery Disease</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Krittanawong, Chayakrit ; Escobar, Johao ; Virk, Hafeez Ul Hassan ; Alam, Mahboob ; Virani, Salim ; Lavie, Carl J. ; Narayan, K M Venkat ; Sharma, Raman</creator><creatorcontrib>Krittanawong, Chayakrit ; Escobar, Johao ; Virk, Hafeez Ul Hassan ; Alam, Mahboob ; Virani, Salim ; Lavie, Carl J. ; Narayan, K M Venkat ; Sharma, Raman</creatorcontrib><description>Lower extremity peripheral artery disease (PAD) is common among patients with several risk factors, such as elderly, smoking, hypertension, and diabetes mellitus. Notably, PAD is associated with a higher risk of cardiovascular complications. Non-invasive interventions are beneficial to improve morbidity and mortality among patients with PAD. Traditional risk factors like smoking, diabetes mellitus, hypertension, and dyslipidemia play a significant role in the development of PAD. Still, additional factors such as mental health, glycemic control, diet, exercise, obesity management, lipid-lowering therapy, and antiplatelet therapy have emerged as important considerations. Managing these factors can help improve outcomes and reduce complications in PAD patients. Antiplatelet therapy with aspirin or clopidogrel is recommended in PAD patients, with clopidogrel showing more significant benefits in symptomatic PAD individuals. Managing several risk factors is crucial for improving outcomes and reducing complications in patients with PAD. Further research is also needed to explore the potential benefits of novel therapies. Ultimately, a comprehensive approach to PAD management is essential for improving morbidity and mortality among patients with this condition.</description><identifier>ISSN: 0002-9343</identifier><identifier>ISSN: 1555-7162</identifier><identifier>EISSN: 1555-7162</identifier><identifier>DOI: 10.1016/j.amjmed.2023.10.028</identifier><identifier>PMID: 37980970</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Aged ; Clopidogrel ; Diabetes Mellitus ; Humans ; Hypertension - complications ; Life Style ; Lifestyle approach ; Lifestyle medicine ; Lower Extremity ; PAD ; Peripheral Arterial Disease - complications ; Peripheral artery disease ; Platelet Aggregation Inhibitors - therapeutic use ; Risk Factors</subject><ispartof>The American journal of medicine, 2024-03, Vol.137 (3), p.202-209</ispartof><rights>2023 Elsevier Inc.</rights><rights>Copyright © 2023 Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c408t-d7df2535110afe0aaed53f35b311582de19d4f5eab7beab2f7991f9997e72dc3</citedby><cites>FETCH-LOGICAL-c408t-d7df2535110afe0aaed53f35b311582de19d4f5eab7beab2f7991f9997e72dc3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S000293432300709X$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37980970$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Krittanawong, Chayakrit</creatorcontrib><creatorcontrib>Escobar, Johao</creatorcontrib><creatorcontrib>Virk, Hafeez Ul Hassan</creatorcontrib><creatorcontrib>Alam, Mahboob</creatorcontrib><creatorcontrib>Virani, Salim</creatorcontrib><creatorcontrib>Lavie, Carl J.</creatorcontrib><creatorcontrib>Narayan, K M Venkat</creatorcontrib><creatorcontrib>Sharma, Raman</creatorcontrib><title>Lifestyle Approach and Medical Therapy of Lower Extremity Peripheral Artery Disease</title><title>The American journal of medicine</title><addtitle>Am J Med</addtitle><description>Lower extremity peripheral artery disease (PAD) is common among patients with several risk factors, such as elderly, smoking, hypertension, and diabetes mellitus. Notably, PAD is associated with a higher risk of cardiovascular complications. Non-invasive interventions are beneficial to improve morbidity and mortality among patients with PAD. Traditional risk factors like smoking, diabetes mellitus, hypertension, and dyslipidemia play a significant role in the development of PAD. Still, additional factors such as mental health, glycemic control, diet, exercise, obesity management, lipid-lowering therapy, and antiplatelet therapy have emerged as important considerations. Managing these factors can help improve outcomes and reduce complications in PAD patients. Antiplatelet therapy with aspirin or clopidogrel is recommended in PAD patients, with clopidogrel showing more significant benefits in symptomatic PAD individuals. Managing several risk factors is crucial for improving outcomes and reducing complications in patients with PAD. Further research is also needed to explore the potential benefits of novel therapies. Ultimately, a comprehensive approach to PAD management is essential for improving morbidity and mortality among patients with this condition.</description><subject>Aged</subject><subject>Clopidogrel</subject><subject>Diabetes Mellitus</subject><subject>Humans</subject><subject>Hypertension - complications</subject><subject>Life Style</subject><subject>Lifestyle approach</subject><subject>Lifestyle medicine</subject><subject>Lower Extremity</subject><subject>PAD</subject><subject>Peripheral Arterial Disease - complications</subject><subject>Peripheral artery disease</subject><subject>Platelet Aggregation Inhibitors - therapeutic use</subject><subject>Risk Factors</subject><issn>0002-9343</issn><issn>1555-7162</issn><issn>1555-7162</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kEtLAzEQx4Motla_gUiOXrbm0XQ3F6HU-oCKgr2HNJnQlN3ummzV_fZmab16mWFm_vP6IXRNyZgSOr3bjnW1rcCOGWE8pcaEFSdoSIUQWU6n7BQNCSEsk3zCB-gixm0KiRTTczTguSyIzMkQfSy9g9h2JeBZ04Ramw3WO4tfwXqjS7zaQNBNh2uHl_U3BLz4aQNUvu3wOwTf9OUSz0ILocMPPoKOcInOnC4jXB39CK0eF6v5c7Z8e3qZz5aZmZCizWxuHRNcUEq0A6I1WMEdF2tOqSiYBSrtxAnQ63ydDHO5lNRJKXPImTV8hG4PY9PZn_v0hKp8NFCWegf1PipWSEYoS_OTdHKQmlDHGMCpJvhKh05RonqaaqsONFVPs88mmqnt5rhhv-5rf01_-JLg_iCA9OaXh6Ci8bAzCV4A0ypb-_83_AK14ohb</recordid><startdate>202403</startdate><enddate>202403</enddate><creator>Krittanawong, Chayakrit</creator><creator>Escobar, Johao</creator><creator>Virk, Hafeez Ul Hassan</creator><creator>Alam, Mahboob</creator><creator>Virani, Salim</creator><creator>Lavie, Carl J.</creator><creator>Narayan, K M Venkat</creator><creator>Sharma, Raman</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202403</creationdate><title>Lifestyle Approach and Medical Therapy of Lower Extremity Peripheral Artery Disease</title><author>Krittanawong, Chayakrit ; Escobar, Johao ; Virk, Hafeez Ul Hassan ; Alam, Mahboob ; Virani, Salim ; Lavie, Carl J. ; Narayan, K M Venkat ; Sharma, Raman</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c408t-d7df2535110afe0aaed53f35b311582de19d4f5eab7beab2f7991f9997e72dc3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Aged</topic><topic>Clopidogrel</topic><topic>Diabetes Mellitus</topic><topic>Humans</topic><topic>Hypertension - complications</topic><topic>Life Style</topic><topic>Lifestyle approach</topic><topic>Lifestyle medicine</topic><topic>Lower Extremity</topic><topic>PAD</topic><topic>Peripheral Arterial Disease - complications</topic><topic>Peripheral artery disease</topic><topic>Platelet Aggregation Inhibitors - therapeutic use</topic><topic>Risk Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Krittanawong, Chayakrit</creatorcontrib><creatorcontrib>Escobar, Johao</creatorcontrib><creatorcontrib>Virk, Hafeez Ul Hassan</creatorcontrib><creatorcontrib>Alam, Mahboob</creatorcontrib><creatorcontrib>Virani, Salim</creatorcontrib><creatorcontrib>Lavie, Carl J.</creatorcontrib><creatorcontrib>Narayan, K M Venkat</creatorcontrib><creatorcontrib>Sharma, Raman</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The American journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Krittanawong, Chayakrit</au><au>Escobar, Johao</au><au>Virk, Hafeez Ul Hassan</au><au>Alam, Mahboob</au><au>Virani, Salim</au><au>Lavie, Carl J.</au><au>Narayan, K M Venkat</au><au>Sharma, Raman</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Lifestyle Approach and Medical Therapy of Lower Extremity Peripheral Artery Disease</atitle><jtitle>The American journal of medicine</jtitle><addtitle>Am J Med</addtitle><date>2024-03</date><risdate>2024</risdate><volume>137</volume><issue>3</issue><spage>202</spage><epage>209</epage><pages>202-209</pages><issn>0002-9343</issn><issn>1555-7162</issn><eissn>1555-7162</eissn><abstract>Lower extremity peripheral artery disease (PAD) is common among patients with several risk factors, such as elderly, smoking, hypertension, and diabetes mellitus. Notably, PAD is associated with a higher risk of cardiovascular complications. Non-invasive interventions are beneficial to improve morbidity and mortality among patients with PAD. Traditional risk factors like smoking, diabetes mellitus, hypertension, and dyslipidemia play a significant role in the development of PAD. Still, additional factors such as mental health, glycemic control, diet, exercise, obesity management, lipid-lowering therapy, and antiplatelet therapy have emerged as important considerations. Managing these factors can help improve outcomes and reduce complications in PAD patients. Antiplatelet therapy with aspirin or clopidogrel is recommended in PAD patients, with clopidogrel showing more significant benefits in symptomatic PAD individuals. Managing several risk factors is crucial for improving outcomes and reducing complications in patients with PAD. Further research is also needed to explore the potential benefits of novel therapies. Ultimately, a comprehensive approach to PAD management is essential for improving morbidity and mortality among patients with this condition.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>37980970</pmid><doi>10.1016/j.amjmed.2023.10.028</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0002-9343 |
ispartof | The American journal of medicine, 2024-03, Vol.137 (3), p.202-209 |
issn | 0002-9343 1555-7162 1555-7162 |
language | eng |
recordid | cdi_proquest_miscellaneous_2892012511 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Aged Clopidogrel Diabetes Mellitus Humans Hypertension - complications Life Style Lifestyle approach Lifestyle medicine Lower Extremity PAD Peripheral Arterial Disease - complications Peripheral artery disease Platelet Aggregation Inhibitors - therapeutic use Risk Factors |
title | Lifestyle Approach and Medical Therapy of Lower Extremity Peripheral Artery Disease |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T02%3A08%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Lifestyle%20Approach%20and%20Medical%20Therapy%20of%20Lower%20Extremity%20Peripheral%20Artery%20Disease&rft.jtitle=The%20American%20journal%20of%20medicine&rft.au=Krittanawong,%20Chayakrit&rft.date=2024-03&rft.volume=137&rft.issue=3&rft.spage=202&rft.epage=209&rft.pages=202-209&rft.issn=0002-9343&rft.eissn=1555-7162&rft_id=info:doi/10.1016/j.amjmed.2023.10.028&rft_dat=%3Cproquest_cross%3E2892012511%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2892012511&rft_id=info:pmid/37980970&rft_els_id=S000293432300709X&rfr_iscdi=true |